T

Traphaco JSC
VN:TRA

Watchlist Manager
Traphaco JSC
VN:TRA
Watchlist
Price: 72 400 VND 0.56%
Market Cap: 3T VND

Relative Value

The Relative Value of one TRA stock under the Base Case scenario is hidden VND. Compared to the current market price of 72 400 VND, Traphaco JSC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TRA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
74
vs Industry
64
Median 3Y
1.4
Median 5Y
1.4
Industry
2.7
vs History
73
vs Industry
31
Median 3Y
15.4
Median 5Y
14.7
Industry
21.6
vs History
63
vs Industry
33
Median 3Y
16.7
Median 5Y
11.9
Industry
16.9
vs History
52
vs Industry
15
Median 3Y
18.3
Median 5Y
13.5
Industry
22.9
vs History
88
vs Industry
37
Median 3Y
2.3
Median 5Y
2.4
Industry
2.3
vs History
74
vs Industry
70
Median 3Y
1.2
Median 5Y
1.2
Industry
3
vs History
79
vs Industry
71
Median 3Y
2.2
Median 5Y
2.2
Industry
5.6
vs History
79
vs Industry
43
Median 3Y
6.9
Median 5Y
6.5
Industry
13.4
vs History
74
vs Industry
41
Median 3Y
8.9
Median 5Y
8.2
Industry
16.7
vs History
65
vs Industry
40
Median 3Y
14.1
Median 5Y
10.1
Industry
16.1
vs History
57
vs Industry
29
Median 3Y
29.6
Median 5Y
14
Industry
18.9
vs History
90
vs Industry
36
Median 3Y
2.2
Median 5Y
2.3
Industry
2

Multiples Across Competitors

TRA Competitors Multiples
Traphaco JSC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
VN
Traphaco JSC
VN:TRA
3T VND 1.2 13.4 5.8 7.4
US
Eli Lilly and Co
NYSE:LLY
977B USD 16.4 53.1 35.6 38.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
528.3B USD 5.7 21 17.2 22.3
CH
Roche Holding AG
SIX:ROG
275.3B CHF 4.5 29.2 12.4 14.5
UK
AstraZeneca PLC
LSE:AZN
217.5B GBP 5 31 108.3 158.5
CH
Novartis AG
SIX:NOVN
219.7B CHF 4.9 19 12 15.5
US
Merck & Co Inc
NYSE:MRK
276B USD 4.3 14.5 10.3 12.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.1 15.6 10.9 12.6
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
147.2B USD 2.3 15 7.6 10.4
P/E Multiple
Earnings Growth PEG
VN
T
Traphaco JSC
VN:TRA
Average P/E: 23.5
13.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.1
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
21
29%
0.7
CH
Roche Holding AG
SIX:ROG
29.2
29%
1
UK
AstraZeneca PLC
LSE:AZN
31
37%
0.8
CH
Novartis AG
SIX:NOVN
19
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.5
15%
1
DK
Novo Nordisk A/S
CSE:NOVO B
15.6
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
15
27%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
VN
T
Traphaco JSC
VN:TRA
Average EV/EBITDA: 400.5
5.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.6
34%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
17.2
9%
1.9
CH
Roche Holding AG
SIX:ROG
12.4
5%
2.5
UK
AstraZeneca PLC
LSE:AZN
108.3
10%
10.8
CH
Novartis AG
SIX:NOVN
12
6%
2
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
1%
10.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
VN
T
Traphaco JSC
VN:TRA
Average EV/EBIT: 1 713
7.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.2
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
22.3
15%
1.5
CH
Roche Holding AG
SIX:ROG
14.5
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
158.5
23%
6.9
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
12.6
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.4
7%
1.5